Design of a new pH-activatable cell-penetrating peptide for drug delivery into tumor cells

被引:16
|
作者
Zhang, Yun [1 ,2 ]
Li, Li [3 ,4 ]
Chang, Linlin [1 ,2 ]
Liu, Hui [1 ,2 ]
Song, Jingjing [2 ]
Liu, Yue [5 ]
Bao, Hexin [1 ]
Liu, Beijun [2 ]
Wang, Rui [2 ]
Ni, Jingman [1 ,2 ]
机构
[1] Lanzhou Univ, Sch Pharm, Lanzhou 730000, Gansu, Peoples R China
[2] Lanzhou Univ, Sch Basic Med Sci, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou, Gansu, Peoples R China
[3] Army Med Univ, Dept Pharm, Daping Hosp, Chongqin, Peoples R China
[4] Army Med Univ, Res Inst Surg, Chongqin, Peoples R China
[5] Lanzhou Gen Hosp Peoples Liberat Army, Dept Pharm, Lanzhou, Gansu, Peoples R China
基金
中国国家自然科学基金; 中央高校基本科研业务费专项资金资助;
关键词
acid-activated; anticancer drug delivery; cell-penetrating peptides; low cytotoxicity; pH-dependent antitumor activity; ANTIMICROBIAL PEPTIDE; CANCER; MEMBRANE; ANALOGS; ACID; TRANSLOCATION; SELECTIVITY; TAT;
D O I
10.1111/cbdd.13537
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cell-penetrating peptides (CPPs) have been considered as potential drug delivery vectors due to their remarkable membrane translocation capacity. However, lack of specificity and extreme systemic toxicity hamper their successful application for drug delivery. Here, we designed a new pH-activatable CPP, LHHLLHHLHHLLHH-NH2 (LH), by substitution of all lysines and two leucines of LKKLLKLLKKLLKL-NH2 (LK) with histidines. As expected, histidine-rich LH could be activated and penetrate into cells at pH 6.0, whereas its membrane transduction activity could be shielded at pH 7.4. In contrast, LK showed no obviously different cellular uptake at both pH conditions. Importantly, LH was significantly less cytotoxicity compared with LK at both pH values, suggesting a better safety for further application. In addition, after conjugation of camptothecin (CPT) with LH, this conjugate displayed remarkably pH-dependent antitumor activity than free CPT and LK-CPT. This study provides a new tumor pH-responsive CPP with low toxicity for selective anticancer drug delivery.
引用
收藏
页码:1884 / 1893
页数:10
相关论文
共 50 条
  • [21] Recent in vivo advances in cell-penetrating peptide-assisted drug delivery
    Kurrikoff, Kaido
    Gestin, Maxime
    Langel, Ulo
    EXPERT OPINION ON DRUG DELIVERY, 2016, 13 (03) : 373 - 387
  • [22] Design strategy of cell-penetrating copolymers for high efficient drug delivery
    Li, Ye
    Feng, Diwen
    Zhang, Xianren
    Cao, Dapeng
    BIOMATERIALS, 2015, 52 : 171 - 179
  • [23] Dimerization of a cell-penetrating peptide leads to enhanced cellular uptake and drug delivery
    Hoyer, Jan
    Schatzschneider, Ulrich
    Schulz-Siegmund, Michaela
    Neundorf, Ines
    BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY, 2012, 8 : 1788 - 1797
  • [24] Tumor selective delivery by cell-penetrating peptides
    Mae, Maarja
    Myrberg, Helena
    Langel, Uelo
    Lindgren, Maria
    JOURNAL OF PEPTIDE SCIENCE, 2008, 14 (08) : 188 - 188
  • [25] The use of cell-penetrating peptides for drug delivery
    Temsamani, J
    Vidal, P
    DRUG DISCOVERY TODAY, 2004, 9 (23) : 1012 - 1019
  • [26] Cell-penetrating peptides, electroporation and drug delivery
    Cahill, K.
    IET SYSTEMS BIOLOGY, 2010, 4 (06) : 367 - 378
  • [27] Characterisation of cell-penetrating peptide-mediated peptide delivery
    Jones, SW
    Christison, R
    Bundell, K
    Voyce, CJ
    Brockbank, SMV
    Newham, P
    Lindsay, MA
    BRITISH JOURNAL OF PHARMACOLOGY, 2005, 145 (08) : 1093 - 1102
  • [28] Oral biodrug delivery using cell-penetrating peptide
    Khafagy, El-Sayed
    Morishita, Mariko
    ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (06) : 531 - 539
  • [29] Cell-penetrating Peptide-mediated Nanovaccine Delivery
    Jiang, Jizong
    CURRENT DRUG TARGETS, 2021, 22 (08) : 896 - 912
  • [30] An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery
    Ding, Yuan
    Sun, Dan
    Wang, Gui-Ling
    Yang, Hong-Ge
    Xu, Hai-Feng
    Chen, Jian-Hua
    Xie, Ying
    Wang, Zhi-Qiang
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2015, 10 : 6199 - 6214